NewCardio IncOver The Counter Market:NWCI
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
NewCardio Inc | 30.0 | 0.0x | --- |
Wellness Center USA Inc | 46.2K | 0.0x | --- |
Motus GI Holdings Inc | 10.0 | 0.0x | --- |
Cyclo3pss Corp | 40.0 | 0.0x | --- |
Medivolve Inc | 171.6K | -0.1x | --- |
Advanced Biomedical Technologies Inc | 42.5K | -0.1x | --- |
Company Information
NewCardio, Inc. (NewCardio), through its wholly owned subsidiary, NewCardio Technologies, Inc. (NewCardio Technologies), operates as a development-stage cardiac diagnostic technology provider focused on the research, development and commercialization of products and services for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of new drugs under development. The Company is focused on the development of a platform technology for its products, which will improve the diagnostic accuracy and value of the standard 12-lead electrocardiogram (ECG). The Company’s core technology platform provides real-time, three-dimensional (3D) analysis of the heart's electrical activity, as detected at the body surface by standard 12-lead ECG electrodes. ECG input signals are typically sampled at 500 hertz (500 times per second).
Contact Information
- Headquarters
- 2350 Mission College Blvd, Suite 1175SANTA CLARA, CA, United States 95054
- Phone
- 510-774-1969
- Fax
- 408-516-5005
Executives
- President
- Vincent Renz
- Chief Executive Officer, Director
- Jess Jones
- Chief Operating Officer
- Gregory Sadowski
- Executive Vice President, Secretary
- Richard Brounstein
- Independent Director
- Michael Hanson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $30.00 |
|---|---|
Revenue (TTM) | $238.6K |
Shares Outstanding | 33.1M |
NewCardio Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.28 |
Book Value | $-0.10 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,076.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
